Decreased 3D observer variation with matched CT-MRI, for target delineation in Nasopharynx cancer

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Rasch, Coen R N ^a   Steenbakkers, Roel J H M ^b   Fitton, Isabelle ^c   Duppen, Joop C ^a   Nowak, Peter J C M ^d   Pameijer, Frank A ^e   Eisbruch, Avraham ^f   Kaanders, Johannes H A M ^g   Paulsen, Frank ^h   van Herk, Marcel ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c HENRI MONDOR HOSPITAL   (France)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY OF MICHIGAN   (United States)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE ANATOMY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE RECONSTRUCTION; NASOPHARYNX CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; THREE DIMENSIONAL IMAGING; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; NASOPHARYNX TUMOR; PATHOLOGY;

HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; NASOPHARYNGEAL NEOPLASMS; OBSERVER VARIATION; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949482002     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-21     Document Type: Article

References (29)

1. Gregoire V, Daisne JF, Bauvois C, et al. [Selection and delineation of lymph node target volumes in head and neck neoplasms]. Cancer Radiother 2001, 5:614-628.
2. Rasch C, Steenbakkers R, van Herk M. Target definition in prostate, head, and neck. Semin Radiat Oncol 2005, 15:136-145. 10.1016/j.semradonc.2005.01.005, 15983939.
3. Pimentel Serra N, van Asselen B, Steenbakkers R, et al. Impact of Observer Delineation Variation on Target Coverage and Dose to Organs at Risk in Nasopharyngeal Cancer Patients. Europ J Cancer 2005, (supplement 3):289.
4. Nowak PJ, Wijers OB, Lagerwaard FJ, et al. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys 1999, 45:33-39.
5. Nowak P, van Dieren E, Sornsen de Koste J, et al. Treatment portals for elective radiotherapy of the neck: an inventory in The Netherlands. Radiother Oncol 1997, 43:81-86. 10.1016/S0167-8140(96)01894-4, 9165141.
6. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004, 233:93-100. 10.1148/radiol.2331030660, 15317953.
7. Palazzi M, Jereczeck-Fossa BA, Soatti C. CT-based delineation of lymph node levels in the neck: can we optimize the Consensus?. Radiother Oncol 2004, 73:383-384. 10.1016/j.radonc.2004.07.024, 15588886.
8. Palazzi M, Soatti C, Bianchi E, et al. Guidelines for the delineation of nodal regions of the head and neck on axial computed tomography images. Tumori 2002, 88:355-360.
9. Wijers OB, Levendag PC, Tan T, et al. A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol 1999, 52:35-42. 10.1016/S0167-8140(99)00076-6, 10577684.
10. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003, 69:227-236. 10.1016/j.radonc.2003.09.011, 14644481.
11. Rasch C, Keus R, Pameijer FA, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1997, 39:841-848.
12. Vansteenkiste J, Fischer BM, Dooms C, et al. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol 2004, 5:531-540. 10.1016/S1470-2045(04)01564-5, 15337482.
13. Steenbakkers RJ, Duppen JC, Fitton I, et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. Radiother Oncol 2005, 77:182-190. 10.1016/j.radonc.2005.09.017, 16256231.
14. Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003, 57:481-488. 10.1016/S0360-3016(03)00570-4, 12957260.
15. Steenbakkers RJ, Duppen JC, Fitton I, et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 2006, 64:435-448.
16. Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 2001, 51:923-931.
17. Mah K, Caldwell CB, Ung YC, et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2002, 52:339-350.
18. Rusthoven KE, Koshy M, Paulino AC. The role of PET-CT fusion in head and neck cancer. Oncology (Williston Park) 2005, 19:241-246.
19. Di Martino E, Nowak B, Hassan HA, et al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000, 126:1457-1461.
20. Scarfone C, Lavely WC, Cmelak AJ, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 2004, 45:543-552.
21. Nowak B, Di Martino E, Janicke S, et al. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999, 38:312-318.
22. Kyzas PA, Evangelou E, Denaxa-Kyza D, et al. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 2008, 100:712-720. 10.1093/jnci/djn125, 18477804.
23. Chao KS, Wippold FJ, Ozyigit G, et al. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002, 53:1174-1184. 10.1016/S0360-3016(02)02881-X, 12128118.
24. King AD, Ma BB, Yau YY, et al. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol 2008, 81:291-298. 10.1259/bjr/73751469, 18344274.
25. Jian JJ, Cheng SH, Prosnitz LR, et al. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma. Cancer 1998, 82:261-267. 10.1002/(SICI)1097-0142(19980115)82:2<261::AID-CNCR3>3.0.CO;2-U, 9445180.
26. Chung NN, Ting LL, Hsu WC, et al. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck 2004, 26:241-246. 10.1002/hed.10378, 14999799.
27. Deurloo KE, Steenbakkers RJ, Zijp LJ, et al. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. Int J Radiat Oncol Biol Phys 2005, 61:228-238.
28. Rasch C, Eisbruch A, Remeijer P, et al. Irradiation of paranasal sinus tumors, a delineation and dose comparison study. Int J Radiat Oncol Biol Phys 2002, 52:120-127.
29. UICC TNM Classification of Malignant Tumours 2002, Wiley, 6, UICC.